Qunova Raises 13.5 Billion Won to Advance Quantum Computing ‘Killer App’
Qunova Raises 13.5 Billion Won to Advance Quantum Computing ‘Killer App’
Quantum computing software startup Qunova has secured 13.5 billion won (about $9.73 million USD) in funding, drawing support from major investors including Korea Development Bank (KDB). The company was established by Professor Lee Jun-goo from KAIST’s Department of Electrical and Electronic Engineering.
According to industry sources on August 3, this Series A round included investment from Quantum Ventures, Company K Partners, and GS Ventures, among others. The strong backing is attributed to its progress in developing the HI-VQE quantum algorithm, which aims to achieve the world’s first quantum advantage. The firm has already demonstrated its competitive strength in quantum chemistry, focusing on new drug discovery and novel material simulation, with intentions to broaden its reach into other sectors.
Their technology has earned both international and industry validation. In April, their proprietary quantum algorithm was registered in IBM’s Qiskit Functions Catalog, which is part of the most widely adopted global quantum computing software platform. Only 10 companies from 9 countries have passed Qiskit’s stringent technical evaluation, now including Qunova among them.
Qiskit connects directly to IBM’s quantum hardware, allowing developers to test their algorithms. Being listed alongside leading companies such as Israel’s Qedma, which recently achieved a valuation in the hundreds of billions of won, marks a significant achievement for them. An investment industry insider commented that Qunova’s Qiskit registration represents more than technical validation, noting, “Among Korean companies, Qunova is currently closest to realizing quantum advantage.”
More Info here – To submit a story to us, address it to “the Editor” here
About Qunova
Qunova is a South Korea-based quantum computing software company specializing in the development of cutting-edge quantum algorithms for next-generation scientific and industrial applications. Founded by Professor Lee Jun-goo of KAIST’s Department of Electrical and Electronic Engineering, Qunova is recognized for its innovation in quantum chemistry simulations, drug discovery, and advanced materials research.
In August 2025, Qunova secured 13.5 billion won (approximately $9.73 million) in a Series A funding round led by the Korea Development Bank (KDB), with support from Quantum Ventures, Company K Partners, GS Ventures, and others. This strong backing highlights investor confidence in Qunova’s proprietary HI-VQE algorithm, which is aimed at delivering the world’s first true quantum advantage.
Qunova’s technological achievements have gained global recognition. The company’s proprietary quantum algorithm was added to IBM’s Qiskit Functions Catalog, the world’s most widely used quantum computing development platform. This inclusion positions Qunova among a select group of only 10 companies from nine countries worldwide that have passed IBM’s technical screening. Qunova stands alongside global leaders such as Israel’s Qedma, known for their significant valuations and industry impact.
Qunova’s commitment to pushing the boundaries of quantum computing is matched by its drive to deliver practical benefits for industry and society. By bridging academic excellence with real-world needs, Qunova is at the forefront of making quantum computing accessible, scalable, and impactful across multiple sectors.
Disclaimer
The information provided in this article is for general informational purposes only and is derived from publicly available sources. While every effort is made to ensure accuracy, we make no representations or warranties, express or implied, regarding the completeness, reliability, or validity of the content. This article does not assert or verify any claims about specific companies, individuals, or organizations. References to external reports, studies, or sources are for contextual purposes only and do not imply endorsement or confirmation of any specific allegations. Readers are advised to conduct their own due diligence and seek professional advice before making business or investment decisions. We disclaim any liability for losses or damages incurred as a result of reliance on the information provided.